Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Long-term specialist care reduces post-RYGB anemia risk
Patients who underwent Roux-en-Y gastric bypass surgery (RYGB) without long-term bariatric specialist follow-up experienced a significantly higher...
News
LUME-Mesa trial: Nintedanib improves PFS in mesothelioma
Addition of nintedanib to pemetrexed plus cisplatin resulted in PFS improvement and AEs were manageable for patients with unresectable malignant...
News
Leukocyte activation test–based elimination diet improves IBS symptoms
Elimination diets guided by leukocyte activation tests reduced symptoms in patients with irritable bowel syndrome in a parallel-group, double-...
News
Retrospective review: No difference in PFS, OS with radiation before PD-1/PD-L1 inhibition
CHICAGO – Findings from this small study conflict with some larger studies that showed a significant PFS benefit in lung cancer patients who...
News
CRP may predict survival after immunotherapy for lung cancer
Median overall survival was more than three times longer for patients with CRP levels at or below 50 mg/L than for those with levels above 50 mg/L...
News
Tocilizumab looks promising for corticosteroid refractory anti-PD-1-related adverse events
CHICAGO – In a review of patients treated with nivolumab, 27 of 34 who were refractory to corticosteroids and treated with tocilizumab for high-...
News
New data prompt update to ACC guidance on nonstatin LDL lowering
The ACC has updated its advice regarding the use of nonstatin therapies following clinical trial results of PCSK9 inhibitors and ezetimibe.
News
PROTECT trial: No DFS benefit with adjuvant pazopanib for high-risk RCC
Adjuvant pazopanib provided no disease-free survival benefit compared with placebo in the randomized phase 3 PROTECT trial of patients with...
News
KW-2478 examined as novel add-on therapy for myeloma
Bortezomib and KW-2478, a novel nonansamycin heat shock protein 90 (Hsp90) inhibitor, had modest activity and was well tolerated in an open-label...
News
WHI hormone trials offer reassurance on long-term mortality risk
New data from the WHI trials suggest that the use of conjugated equine estrogens alone or with medroxyprogesterone acetate is safe for 5-7 years...
News
Worsening osteoporosis care for RA patients shows need for action
Appropriate osteoporosis care in patients with rheumatoid arthritis is suboptimal and has been declining steadily over the past decade, but new...
News
New AML approvals changing the treatment landscape
A recent flurry of new drug approvals for acute myeloid leukemia are raising questions about how to incorporate these costly new therapies into...
News
New recommendations tout biosimilars for rheumatologic diseases
An international multidisciplinary task force came up with five overarching principles for the use of biosimilars and eight specific...
News
Vaccinate and consider tofacitinib monotherapy to prevent herpes zoster in RA
Two studies offer the best evidence yet in how to use zoster vaccination prior to starting tofacitinib and how to reduce risk of the infection...
News
FDA alert: pembrolizumab ups mortality risk in multiple myeloma
The use of pembrolizumab (Keytruda) in combination with dexamethasone and either lenalidomide or pomalidomide is associated with an increased risk...